These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8756391)

  • 21. [Laparoscopy in (apparently) benign ovarian tumors between benefit and catastrophy and the deceptive safety of laparoscopic lap sacs].
    Wallwiener D; Diel IJ; Sohn C; Grischke EM; Brandsch R; Kurek R; Heberling D; Bastert G
    Zentralbl Gynakol; 1996; 118(2):53-61. PubMed ID: 8851090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guest editor's introduction. Ovarian tumors: perplexing patterns, perspicacious pathologists.
    Young RH
    Semin Diagn Pathol; 2001 Aug; 18(3):155-60. PubMed ID: 11554664
    [No Abstract]   [Full Text] [Related]  

  • 23. Practice protocol for the examination of specimens from patients with lung cancer. Cancer Committee. Task Force on the Examination of Specimens from Patients with Lung Cancer.
    Nash G; Hutter RV; Henson DE
    Arch Pathol Lab Med; 1995 Aug; 119(8):695-700. PubMed ID: 7646325
    [No Abstract]   [Full Text] [Related]  

  • 24. The current status of surgical staging of ovarian serous borderline tumors.
    Lin PS; Gershenson DM; Bevers MW; Lucas KR; Burke TW; Silva EG
    Cancer; 1999 Feb; 85(4):905-11. PubMed ID: 10091769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staging and follow-up of ovarian cancer. American College of Radiology. ACR Appropriateness Criteria.
    Fishman EK; Mendelson E; Böhm-Vélez M; Bree R; Finberg H; Hricak H; Laing F; Sartoris D; Thurmond A; Goldstein S; Walsh J
    Radiology; 2000 Jun; 215 Suppl():899-902. PubMed ID: 11037515
    [No Abstract]   [Full Text] [Related]  

  • 26. Protocol for the examination of specimens removed from patients with carcinomas of the upper aerodigestive tract: carcinomas of the oral cavity including lip and tongue, nasal and paranasal sinuses, pharynx, larynx, salivary glands, hypopharynx, oropharynx, and nasopharynx. Cancer Committee, College of American Pathologists.
    Min KW; Houck JR
    Arch Pathol Lab Med; 1998 Mar; 122(3):222-30. PubMed ID: 9823859
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of diaphragmatic wash and scrape specimens in staging of women with ovarian cancer.
    Eltabbakh GH; Mount SL
    Gynecol Oncol; 2001 Jun; 81(3):461-5. PubMed ID: 11371139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors.
    Schindl M; Schoppmann SF; Ströbel T; Heinzl H; Leisser C; Horvat R; Birner P
    Clin Cancer Res; 2003 Feb; 9(2):779-85. PubMed ID: 12576450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germ cell tumors.
    Hawkins EP
    Am J Clin Pathol; 1998 Apr; 109(4 Suppl 1):S82-8. PubMed ID: 9533752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Borderline ovarian tumors: an update].
    Tulpin L; Rouzier R; Morel O; Malartic C; Daraï E; Barranger E
    Gynecol Obstet Fertil; 2008 Apr; 36(4):422-9. PubMed ID: 18356093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer.
    Watson P; Bützow R; Lynch HT; Mecklin JP; Järvinen HJ; Vasen HF; Madlensky L; Fidalgo P; Bernstein I;
    Gynecol Oncol; 2001 Aug; 82(2):223-8. PubMed ID: 11531271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO].
    Schmalfeldt B; du Bois A; Burges A; Emons G; Fink D; Gropp M; Hasenburg A; Jäger W; Kimmig R; Kiechle M; Kommoss F; Kreienberg R; Kuhn W; Lück HJ; Meier W; Münstedt K; Ortmann O; Pfisterer J; Richter B; Runnebaum I; Schröder W; Sehouli J; Tanner B; Wagner U; Weis J
    Zentralbl Gynakol; 2006 Feb; 128(1):11-7. PubMed ID: 16450281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study.
    Moore DH; Kauderer JT; Bell J; Curtin JP; Van Le L
    Gynecol Oncol; 2004 Aug; 94(2):368-74. PubMed ID: 15297174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [ZNF217 gene was detected in ovarian serous cystadenocarcinoma by fluorescence in situ hybridization].
    Zhong M; Li J; Ding YQ; Song LL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):665-7. PubMed ID: 17160949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of chemotherapy use for women with ovarian cancer: a population-based study.
    Cress RD; O'Malley CD; Leiserowitz GS; Campleman SL
    J Clin Oncol; 2003 Apr; 21(8):1530-5. PubMed ID: 12697877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.
    Lopez-Beltran A; Bassi P; Pavone-Macaluso M; Montironi R
    Eur Urol; 2004 Mar; 45(3):257-66. PubMed ID: 15036668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification of Psammoma Bodies in the Revised College of American Pathologists Thyroid Cancer Protocol.
    Chernock RD; Lewis JS
    Arch Pathol Lab Med; 2015 Aug; 139(8):967. PubMed ID: 26230586
    [No Abstract]   [Full Text] [Related]  

  • 39. What is needed to satisfy the American College of Surgeons Commission on Cancer (COC) requirements for the pathologic reporting of cancer specimens?
    Connolly JL; Fletcher CD
    Hum Pathol; 2003 Feb; 34(2):111. PubMed ID: 12612876
    [No Abstract]   [Full Text] [Related]  

  • 40. Papanicolaou Society of Cytopathology guidelines for educational notes, disclaimers, and similar comments on reports of cervical cytology specimens.
    Papanicolau Society of Cytopathology Practice Guidelines Task Force
    Diagn Cytopathol; 2003 May; 28(5):282-5. PubMed ID: 12722126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.